Preston has had the opportunity to work across multiple stages of the life science sector focused on developing and investing in new therapeutics. He co-founded Agent Capital, a biotech VC firm focused on investing in novel, differentiated therapeutics that address unmet patient need, investing across all stages of clinical development.
Prior to Agent Capital, Preston was a Senior Associate in Baxalta's corporate venture arm, where he was responsible for supporting new investment opportunities and performing scientific and financial analyses. Before venture capital, Preston worked at Bayer Pharmaceuticals as an associate focused on business development, and also at Bristol-Myers Squibb as an analyst for the medical affairs organization supporting clinical trial operations.
Education, Personal, and Fellowship
Preston attended the University of Connecticut where he earned BS, PharmD, and MBA degrees.
He is closely tied into the venture and entrepreneur communities on the East coast, primarily in Cambridge/Boston area and the greater NYC region.
Preston is serving his fellowship at Agent Capital in Cambridge, Massachusetts under the mentorship of Geeta Vemuri, Founding Managing Partner; he is a member of Class 23